OCTN-1 (novel organic cation transporter) was recently identified as the receptor for EGT and responsible for its intracellular accumulation. This study of keratinocytes (NHEK) and fibroblasts (NHDF) indicate
A $175,000 capital grant from the state of New York’s Empire State Development Corporation for job creation is said to have played a key role in the decision
The service will enable women to bank their eggs during their reproductive prime – ideally by age 35 or younger – for potential use in the future. To
The fluorescent molecule was developed in Professor Kazunori Koide’s lab at the University’s Department of Chemistry. The technology allows the end user to quantitatively detect palladium or platinum
The microsome product line formulated to deliver different classifications of cytochrome P450 (CYP) enzyme activity, high levels for inhibitions studies (InVitroCYP H-class), moderate levels for metabolic studies (InVitroCYP
US Renal Care plans to expand Eumana’s unique service offering of home dialysis in other markets where it already operates. By adding these services in other markets, US
If certain performance milestones are achieved in 2008, a further consideration, up to a maximum of $10 million may be payable. Peter Gray, CEO of Icon, said: “The
In the agreement, Vaccinogen has obtained exclusive license to OncoVAX Active Specific Immunotherapy as well as an important component of the product TICE BCG. The vaccine is made
DelSite Biotechnologies, Carrington’s wholly owned subsidiary, is developing GelSite polymer. The patent specifically covers the in-situ gelation (gelling in place) powder technology based on GelSite polymer. GelVac, the
A group of ten patients applied a 10% alpha-hydroxy acid (AHA) cream each evening for two weeks prior to in-office procedures. This conditioning phase served to acclimate the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.